The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.

Ippei MiyagawaKazuhisa NakanoShingo NakayamadaShigeru IwataKentaro HanamiShunsuke FukuyoYasuyuki TodorokiAkio KawabeYusuke MiyazakiYoshino InoueMasanobu UenoNaoaki OhkuboYuya FujitaYoshiya Tanaka

Published in: International journal of rheumatic diseases (2020)

The use of HCQ effectively improved SLEDAI scores and was a predictive factor for the prevention of SLEDAI flare. Therefore, HCQ may be considered a potential mainstay of maintenance therapy.

Keyphrases

healthcare
palliative care
quality improvement
stem cells
risk assessment
mesenchymal stem cells
human health
climate change
chronic pain
health insurance